Dr. Tepper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
30 Buxton Farm Rd
Ste 230
Stamford, CT 06905Phone+1 203-914-1900
Education & Training
- Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1981 - 1984
- University of Washington School of MedicineJunior Residency, 1980 - 1981
- Boston University Medical CenterInternship, Internal Medicine, 1979 - 1980
- Weill Cornell MedicineClass of 1979
- Yale CollegeBA, Psychobiology, Cum Laude, 1975
Certifications & Licensure
- CT State Medical License 1999 - 2025
- NY State Medical License 1999 - 2025
- PA State Medical License 2023 - 2024
- VT State Medical License 2022 - 2024
- NH State Medical License 2015 - 2023
- OH State Medical License 2008 - 2017
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Fellow American Neurological Association, 2013
- Fellow American Headache Society, 2012
- Super Doctors Cleveland, 2012
- Join now to see all
Clinical Trials
- MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Implant Start of enrollment: 2006 Feb 01
- Staccato Prochlorperazine in Migraine (in Clinic) Start of enrollment: 2005 Mar 01
- fMRI of the Brainstem in Migraine Sufferers and Controls. Does Iron Deposition Correlate With Progression of Disease? Start of enrollment: 2009 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsMultimodal Migraine Management and the Pursuit of Migraine Freedom: A Narrative Review.Andrew M Blumenfeld, Richard B Lipton, Stephen Silberstein, Stewart J Tepper, Larry Charleston 4th
Neurology and Therapy. 2023-10-01 - 4 citationsErenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.Stewart J Tepper, Huma U Sheikh, Carrie O Dougherty, Stephanie J Nahas, Paul K Winner
Headache. 2022-04-01 - 27 citationsUnderstanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and...Ariane K. Kawata, Neel Shah, Jiat Ling Poon, Shannon Shaffer, Sandhya Sapra
Headache. 2021-03-01
Journal Articles
- Anti‐Calcitonin Gene‐Related Peptide (CGRP) Therapies: Update on a Previous Review After the American Headache Society 60th Scientific Meeting, San Francisco, June 2018Stewart Tepper, MD, Headache: The Journal of Head and Face Pain
- Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine TrackerDawn C Buse, Stewart J Tepper, David W Dodick, Richard B Lipton, Headache: The Journal of Head and Face Pain
- Migraine: barriers for care.Sheftell FD, Tepper SJ, Bigal ME, Neurol Sci. 2005;26 Suppl 2:s140-2
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Botulinum Toxin in the Preventive Treatment of Refractory Headaches.Tepper SJ, Bigal ME, Sheftell FD, Rapoport AM, International Headache Research Seminars, Copenhagen, Denmark
- Short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms (SUNA)—a case report.Volcy M, Tepper SJ, Rapoport AM, Sheftell FD, Bigal MD, Cephalalgia 2005:25:470–472
- Rational Therapy for Headache.Cady RK, Rosum RW, Solomon GD, Tepper SJ, Institute for Contemporary Pharmacy Research
- Join now to see all
Lectures
- Prevention of Headache Recurrence, Migraine.American Academy of Neurology, Boston, MA
- Pathophysiology and Pharmacology of Migraine.XVI Annual US Army Medical Department Neurology Conference. Madigan Army Medical Center, Tacoma, WA
- When should we use 5HT agonists and when might they be used in preference to other treatments such as ergotamines and combination therapies, in New Horizons in Migraine.XVIth World Congress of Neurology, Buenos Aires, Argentina
- Join now to see all
Other
- Migraine: improved outcomes in patients previously poorly responsive to therapy.Dowson AJ and Tepper SJ, Int J Clinic Practice 2008;62(12):1822-1824
- Rescue Me: Rescue Medication for Migraine.Whyte C, Tepper SJ, Evans R, Headache 2010;50(2):307-313
- Adherence to Acute Migraine Medication: What Does It Mean, Why Does It Matter?Katic´ BJ, Krause SJ, Tepper SJ, Hu HX, Bigal ME, Headache 2010;50(1):117-132
- Join now to see all
Press Mentions
- Satsuma Pharmaceuticals and SNBL Announce Publication of STS101 (Dihydroergotamine Nasal Powder) Pivotal Phase 3 ASCEND Study in CNS DrugsOctober 8th, 2024
- Erenumab Reduces Nonopioid Medication Overuse Headache in Chronic MigraineOctober 4th, 2024
- Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic MigraineSeptember 19th, 2024
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: